Fourth Launches Fourth iQ 3.0, Giving Senior Restaurant Leaders Control and Visibility Over Store Performance February 26, 2026 Fourth, the leading provider of workforce and inventory management solutions for the hospitality industry, today announced the launch of Fourth iQ 3.0, introducing a significant new layer of above-store AI capabilities built for executives and operations teams responsible for multi-location performance. The release complements Fourth iQ’s in-store AI capabilities, including Forecasting and Next Best Actions, [...]
Lone Star Agrees to Acquire Central London Office Building February 26, 2026 Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real Estate Fund VII, L.P. has reached an agreement to acquire 90 Whitfield Street in London, UK from Derwent London. The property, located in central London’s West End sub-market of Fitzrovia, is comprised of 107,000 total square-feet with 99,000 square-feet dedicated to [...]
CoStar Data Show Sharp London Office Yield Compression in 2025 February 26, 2026 Rising investor demand drove London office yields to their lowest level since 2023, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226000995/en/ Based on a three-period trailing average, the transaction-based office yield [...]
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing February 25, 2026 VH184, the first, third‑generation integrase inhibitor in development shows potential for up to twice-yearly dosing intervals Additional in-vitro data on VH184 demonstrate improved potency and an enhanced resistance profile versus bictegravir VH499 demonstrates good tolerability, supporting twice-yearly dosing intervals
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen February 25, 2026 94% of adults on stable therapy maintained viral suppression with intravenous lotivibart dosed every four months in combination with long-acting cabotegravir These phase IIb results reinforce lotivibart’s ultra long-acting potential, with the trial progressing to evaluate a twice-yearly intravenous dosing interval
Extend Launches CIP: a Cultural Intelligence Platform Empowering Marketers to Plan, Manage, and Monitor Campaigns Directly Through Its Marketing Platform February 25, 2026 Extend CIP unifies years of product and agency experience into a single platform for marketers across the Arab world, launching with the region's largest influencer ad library and end-to-end campaign tools
Airspan Networks Expands 5G In-Motion Platform into Defense MANET, High-Altitude Platforms, and Drones February 25, 2026 Introducing a resilient advanced communications bridge between terrestrial and aerial networks
NYU Abu Dhabi and RTW Investments Announce Strategic Collaboration to Advance Healthcare and Life Sciences Innovation February 25, 2026 Partnership will deliver executive programs and convene global investors, policymakers, and experts to strengthen the region’s healthcare ecosystem
Chemify and Sanacor Collaborate to Discover and Develop Small Molecule Therapies for Cardiometabolic Diseases February 25, 2026 Partnership to use Chemify’s programmable chemistry technology and Sanacor’s translational biology expertise to accelerate small-molecule discovery addressing mitochondrial dysfunction
Bureau Veritas: Sector-Leading Organic Revenue Growth of 6.5% in FY 2025 February 25, 2026 Strong margin improvement to 16.3% in FY 2025 Positive growth outlook with continued margin expansion in 2026 New EUR 200 million share buyback